Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051322
Abstract: Simple Summary Thermosensitive liposomes (TSL) are lipid-based nanoparticles that release the encapsulated drug in response to heat. TSL are administered systemically, e.g., by intravenous infusion, and circulate within the bloodstream for an extended duration. When… read more here.
Keywords: tsl; tumor delivery; drug; delivery ... See more keywords